# @elilillyco on Instagram

- **Type:** Image
- **Original URL:** https://www.instagram.com/p/ClBnG3otYjU
- **Gondola URL:** https://gondola.cc/posts/64294503-elilillyco-instagram
- **Thumbnail:** https://img.gondola.cc/tr:w-,h-,fo-auto/postThumbnails/3878c7538d.jpg
- **Posted:** 2022-11-16T14:28:05.000+00:00
- **Account Owner:** Eli Lilly and Company (@elilillyco) — https://gondola.cc/elilillyco

## Caption

#WeAreLilly - 37,000 global employees #PoweredbyPurpose

"Alzheimer's disease is relentless. It can be a thief of one's humanity, and although that seems very dark, it serves as motivation to rewrite the narrative to something brighter.

Relentless is also how I describe Lilly's commitment to Alzheimer’s. I have been inspired to see the analog of Colonel Lilly's "take what you find here and make it better and better" come to bear in our clinical trial programs. With each negative study, we have learned something and improved the following study so we can get closer and closer to the answer on behalf of patients.

As a behavioral neurologist and clinician educator in academic practice, I spent my days caring for patients with neurodegenerative diseases and their families, conducting clinical research, and teaching others about dementia. In clinical practice, developing a personal relationship with a patient and their family, I often observed the devastation and dynamics of living with Alzheimer’s disease and consistently shared my belief in a future with disease-modifying therapies.

I would frequently tell patients and families when referring them to a clinical trial — 'there are people much smarter than me working on this problem day and night. Be assured that during the period of my career, there will be a medicine that will meaningfully impact this illness.' Finally, one afternoon I left the exam room and had an epiphany: why wouldn't I want to play a more significant role in such progress?

My clinical experience prompted me to transition to a role in industry, even though delivering new medicines for patients is often a longer and more complicated journey than expected.

I am grateful to be both emotionally invested in our medical efforts and purposefully connected with the broader team as we continue to innovate toward a brighter future for patients and families living with Alzheimer’s."

Brandy Matthews, MD
Associate VP-Medical Affairs – Neuroscience

## Stats

- **Views:** 0
- **Likes:** 146
- **Shares:** 0
- **Comments:** 36

## Tags

poweredbypurpose, wearelilly

---
Copyright (c) Gondola